Date: 17 – 18 August 2018. The event will commence on Friday at 10am and conclude on Saturday at 4pm.
Venue: Sheraton Melbourne Hotel, 27 Little Collins Street, Melbourne, Victoria
Course Convener: A/Prof Nick Pavlakis supported by Dr Antony Mersiades
Applications: Places are limited to a maximum of 50 people.
Travel and accommodation: Will be provided to successful applicants.

This intensive and active learning program where participants are divided into small groups with an allocated preceptor, who is a senior ALTG member with clinical expertise in lung cancer management. Participants are expected to make a short presentation of a selected clinical study deemed to be of high importance to clinical practice, to their peers with active discussion.

The objectives of the program are:

• to critically appraise and evaluate key evidence supporting the evolution of clinical practice of lung cancer diagnosis and management, in early and advanced settings, incorporating supportive care, modern treatments and technologies, including modern molecular technology and immune-profiling for selection of targeted therapies and immunotherapy.
• to appreciate the importance of multidisciplinary team care
• to appreciate the importance of clinical inquiry as the basis for clinical research
• to appreciate the basics of clinical trial design